By: Tiantian Zhang1, Yiqun Han2, Lei Deng3 1. Department of Internal Medicine, University of Central Florida, Pensacola, FL 2. Mayo Clinic, Rochester, MN 3. University of Washington/Fred Hutch Cancer Center, Seattle, WA
MoreBy: Tiantian Zhang1, Yiqun Han2, Lei Deng3 1. Department of Internal Medicine, University of Central Florida, Pensacola, FL 2. Mayo Clinic, Rochester, MN 3. University of Washington/Fred Hutch Cancer Center, Seattle, WA
MoreBy: Zhiting Tang1, Lei Deng2 1. Unity Hospital, Rochester Regional Health, Rochester, NY2. University of Washington/Fred Hutch Cancer Center, Seattle, WA LAURA: A randomized, double-blind, Phase III study of chemoradiation followed
MoreSEATTLE, WA – The Binaytara Foundation, a non-profit organization dedicated to improving healthcare in underserved communities, is proud to announce the 2023 Summit on Cancer Health Disparities (SCHD), which will take place
MoreThe Binaytara Foundation hosted a CME conference, CheckPoint Inhibitors in Lung Cancer, on March 26, 2022, at the Delta Hotels in Everett, Washington. This half-day conference was the first in a series
More